Growth Metrics

Biofrontera (BFRI) Total Liabilities: 2020-2025

Historic Total Liabilities for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $18.0 million.

  • Biofrontera's Total Liabilities rose 38.58% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 38.58%. This contributed to the annual value of $17.7 million for FY2024, which is 23.64% down from last year.
  • Per Biofrontera's latest filing, its Total Liabilities stood at $18.0 million for Q3 2025, which was down 27.46% from $24.8 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Total Liabilities registered a high of $41.9 million during Q4 2021, and its lowest value of $10.7 million during Q2 2024.
  • Moreover, its 3-year median value for Total Liabilities was $20.6 million (2023), whereas its average is $20.8 million.
  • In the last 5 years, Biofrontera's Total Liabilities plummeted by 60.73% in 2024 and then soared by 132.67% in 2025.
  • Biofrontera's Total Liabilities (Quarterly) stood at $41.9 million in 2021, then crashed by 35.52% to $27.0 million in 2022, then declined by 14.32% to $23.1 million in 2023, then dropped by 23.64% to $17.7 million in 2024, then skyrocketed by 38.58% to $18.0 million in 2025.
  • Its Total Liabilities stands at $18.0 million for Q3 2025, versus $24.8 million for Q2 2025 and $16.1 million for Q1 2025.